SVAS BIOSANA S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.25 EUR | +0.61% |
|
+2.48% | +3.12% |
| Apr. 16 | Svas Biosana increases profit in 2023; ex-dividend proposed | AN |
| Apr. 15 | Mib bullish; Leonardo on top | AN |
| Sales 2023 * | 118M 127M | Sales 2024 * | 124M 133M | Capitalization | 44.27M 47.54M |
|---|---|---|---|---|---|
| Net income 2023 * | 4M 4.3M | Net income 2024 * | 6M 6.44M | EV / Sales 2023 * | 0.6 x |
| Net Debt 2023 * | 27.1M 29.11M | Net Debt 2024 * | 27.4M 29.43M | EV / Sales 2024 * | 0.58 x |
| P/E ratio 2023 * |
9.43
x | P/E ratio 2024 * |
7.26
x | Employees | 374 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 31.42% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.22% | ||
| 1 week | +0.62% | ||
| Current month | -3.34% | ||
| 1 month | -3.34% | ||
| 3 months | +9.16% | ||
| 6 months | +14.08% | ||
| Current year | +1.25% |
1 week
7.85
8.20
1 month
7.808.55
Current year
7.208.60
1 year
6.909.80
3 years
6.9016.30
5 years
6.9016.30
10 years
6.9016.30
| Managers | Title | Age | Since |
|---|---|---|---|
Umberto Perillo
CEO | Chief Executive Officer | 63 | 12-03-27 |
Andrea Efficace
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 15-06-29 | |
Umberto Perillo
CEO | Chief Executive Officer | 63 | 12-03-27 |
| Chairman | 74 | 12-03-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 8.25 | +0.61% | 1 560 |
| 24-04-25 | 8.2 | 0.00% | 0 |
| 24-04-24 | 8.2 | 0.00% | 604 |
| 24-04-23 | 8.2 | +1.23% | 30 |
| 24-04-22 | 8.1 | +0.62% | 540 |
Real-time Borsa Italiana, April 26, 2024 at 03:53 am EDT
More quotes
Svas Biosana Srl is an Italy-based company, which manufactures and markets medical devices and pharmaceutical products. The Company consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The Company is the subsidiary of Svas group. Test Data.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.2
EUR
Average target price
14.2
EUR
Spread / Average Target
+73.17%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.25% | 47.42M | |
| -2.92% | 185B | |
| -3.80% | 105B | |
| -5.48% | 66.59B | |
| +11.22% | 54.66B | |
| +16.74% | 47.78B | |
| +4.06% | 41.26B | |
| +4.56% | 26.95B | |
| +1.64% | 26.37B | |
| +12.96% | 24.8B |
- Stock Market
- Equities
- SVS Stock
